CDH Investments
鼎晖投资
CDH Investments is a major Chinese PE firm whose real estate arm, founded in 2009 and one of China's earliest real estate equity funds, has managed roughly 20 property funds across China, the US, and Japan with nearly 10 billion yuan under management; per 暗涌Waves, in late 2024 it raised a 5 billion yuan logistics infrastructure fund — co-managed with JD.com's property arm JD Property under a Co-GP model, with insurance LPs including China Post Insurance and Generali Life — targeting modern logistics parks anchored by long-term blue-chip tenants . Beyond real estate, CDH is known for an unusually industry-tied approach to buyouts: it backed WH Group's $7.1 billion acquisition of Smithfield and partnered with Joyoung's parent to acquire SharkNinja, later becoming the second-largest shareholder of the merged JS Global Life when it listed in Hong Kong in late 2019 .
AI-generated — may contain errors, please verify.
Coverage
Gaorong Ventures Report: Physical AI, Domestic Computing Power, Controllable Nuclear Fusion, and Medical Innovation Companies Close Major Funding Rounds
From the continuous leap in model capabilities to hard tech crossing the thresholds of engineering and industrialization, a new wave of technological innovation is accelerating toward the real world.
From 30 Million to 3 Billion: Three Rounds, Wanwu Capital | Luzhou Shengmingli
VAST recently announced the completion of its Series B and B+ funding rounds.
Weiling Medical raises over 100 million yuan to accelerate clinical translation of implantable brain-computer interfaces
Cracking the Diagnostic and Treatment Dilemma of Severe Brain Injury Through Medical Brain-Computer Interfaces
"Zhengqi Future" Closes Hundreds of Millions of RMB in Angel Round Financing, Linear Capital Invests Across Both Rounds | Linear Portfolio
Building the foundational infrastructure for next-generation physical AI.
"Zhongsheng Quanpeptide" Raises Over 300 Million Yuan in Series C Funding to Accelerate Global Expansion of Peptide-Based Innovative Drugs
It has secured multiple international partnerships with MNCs including Novartis and Eli Lilly and Company.
Investment and funding heat up alongside spring temperatures | Unity Ventures Spring Chronicle
Portfolio companies have raised more than 5 billion yuan in total funding.
"Micro-Nano Starry Sky" Debuts at Shanghai Commercial Aerospace Conference: The "Underwater Anchor Tenant" That Raised 1.56 Billion Yuan in a Year | Xinxing PORTFOLIO
A leading domestic high-end satellite manufacturer.
5Y News | Syneron Bio Closes $150 Million Series B Round
Syneron Bio today announced the completion of its Series B funding round.
Former vivo star product manager Song Ziwei's AI hardware startup V-Light bags over 100 million yuan in funding, Unity Ventures continues to follow on
Unity Ventures remains bullish on opportunities in AI hardware and globalization.
Beware of Fake VC Scams
"Private funds raise capital only from specific qualified investors who meet certain criteria." Qiming Venture Partners reminds all investors and entrepreneurs to stay vigilant, verify authenticity, and avoid financial losses.
Yunqi Capital | Lead Series A investor Neolix raises over $600 million in Series D, with Yunqi Capital continuing to increase its stake
Accompanying the World's Largest L4 RoboVan Supplier in Its Continuous Evolution
AusperBio raises $63M in Series B2 funding co-led by Qiming Venture Partners
Haibo Pharmaceutical is a clinical-stage innovative drug company focused on the R&D of self-developed targeted small nucleic acid therapeutics, with "achieving clinical cure for chronic hepatitis B" as its core mission.
Exclusive | Luminous Sail Tech Raises 130 Million RMB in Three Months, with CATL Co-founder, Shokz, and Goertek Joining
The age of warring gods is back.
Where Are the Bold State Investors?
Breaking Down the Most Active Local State-Owned Capital.
The CVC-Qiao Jiangnan Buyout: Zhang Lan in the Spotlight, Public Opinion in the Shadows | Mega M&A
Who actually owes whom?
2024, When Everyone Stands at a Crossroads: 96 Investors' Decisions
Deciding is easy. Waiting is hard.
Year-end good news: CDH Investments has raised 5 billion yuan for logistics investments.
Insurance capital is turning its attention to real estate investments.
Countless Lies About M&A in China, and One Truth
All we hear are footsteps on the stairs, but no one ever comes down.
The Alibaba investment executive who bet big on Kimi has left, and she sent off her departure with a rock song
"To be part of the wave can't stop."
If wisdom lacks the courage of execution, it is all in vain | 5Y News Monthly
The big news from last month.
5Y News | 5Y Capital Portfolio Company ReviR Therapeutics Raises $30 Million in Series A Funding
Continuing to advance "oral gene therapy" through AI+RNA.
Linear Capital Leads Angel Round Investment in Yuansuan Technology, Which Completes Hundreds of Millions of Yuan in Series C1 Funding
Recently, Yuansuan Technology, a Linear Capital angel-round lead investment, completed a Series C1 raise of several hundred million RMB. This round was jointly invested by CITIC Securities, Zhejiang Financial Holdings, and others, with existing shareholders including CDH Venture Capital continuing to increase their stakes.
WeLing Medical Completes Angel Plus Round to Advance Fully Implantable Medical-Grade Brain-Computer Interface System
Accelerating the clinical translation of brain-computer interface technology.
A Clever Exit Move: Turning 180 Million in Three Years
What "divine" new money-making method?
Conversations with 29 Tech Investors: There Are Treasures, But No Treasure Map
Investing in tech is definitely the right call, but consensus remains scarce.
Allen Luo and Zheng Gang: Let the Law Be the Law, and Let Emotions Be Emotions
A story about a VC-founder relationship hitting rock bottom.
Yinjia Biotech Closes Nearly RMB 100 Million Series A Round to Accelerate Buildout of Upstream Core Protein Ingredient Synthetic Biology Platform
Staying true to our mission as "protein craftsmen."
Capital O Closes First Fund, Post-90s GP Enters the Stage
Technological breakthroughs deserve more attention than market turbulence.
We Analyzed 1,000 LP Commitments and Found 30 Hidden Top Family Offices
They are also a microcosm of China's commercial evolution.
MaHui | MaHui Member "RuiGu Mall" Announces $400 Million Funding Round Completed Within Six Months — Previous Investor Source Code Capital Provided Continuous Support Across Five Rounds
Becoming the "Digital Brain" of the Industrial Goods Sector
Buyouts in China: A "Boy Who Cried Wolf" Fable
After so many cycles of euphoria and heartbreak, will Chinese buyouts finally deliver a different ending this time?
Robots, AI, and Simulation Technologies Accelerate Industrial Adoption | Rongbao · June
Technology drives industrial transformation.
Style3D Completes Nearly $100 Million Pre-B+ Round to Build Digital Fashion Infrastructure
Building out new digital infrastructure and accelerating overseas expansion.
MaHui | Source Code Capital's Xingchen Zhang Named to Cyzone's 40 Under 40 Investors List
"Finding tech founders full of conviction"
Investors in the Wheat Field
A Nerve-Ending-Style Descent into the Investment World: Into the Fields and Countryside.
Global SaaS, New Brands, and Biopharma Companies Close New Funding Rounds | Rongbao · February
The vitality of spring.
Global E-commerce SaaS Platform Dianxiaomi Closes $100 Million Series C, Now Serving Over 1.2 Million Merchants Worldwide
Helping global e-commerce sellers boost efficiency and core competitiveness.
February: When the Tiger Roars, the Wind Rises | 5Y News Monthly
The big news from last month.
5Y News | AI+RNA Startup ReviR Therapeutics Closes Tens of Millions of Dollars in Pre-A Round
Using AI algorithms and gene technology to drive targeted RNA drug development.
Gaorong Monthly · December | Gaorong Ventures and Its Frontier Tech / Consumer / Healthcare / Enterprise Service Portfolio Companies Win Multiple Annual Awards
Its technological and innovative capabilities have won recognition.
3 Biopharma Companies Raise Over 1 Billion Yuan Combined | FreeS Family Funding News · October–November
Firmly bullish on the development of biomedical innovation in China
Source Code Capital portfolio company Ruigu announced the completion of a $250 million Series D funding round, with existing shareholder Source Code Capital continuing to increase its stake.
Accelerating the digital transformation of China's industrial goods sector.
Yinjia Biotech Closes Pre-A Round, Advancing Its High-End Protein Platform to New Heights
Build a leading domestic "protein artisan" platform.
Rongbao · June | BOSS Zhipin and Dingdong Maicai successfully go public; medical, industrial upgrade, and chip companies close new funding rounds
Xingji, Dongjing Yiwan, Qitan Technology, and other companies have completed new funding rounds.
Qitan Tech Raises Over 400 Million Yuan in Series B, Leading the Nanopore Gene Sequencer Race
China's first fully self-developed nanopore gene sequencer is slated for mass production later this year.
Source Code Capital portfolio company "Ruigu Mall" announces completion of hundreds of millions of RMB in Series C2 funding; existing shareholder Source Code Capital continues to increase its stake
Covering nearly 100,000 end-customer locations across dozens of cities, with hundreds of thousands of electromechanical tools and hardware products delivered daily.
Gaorong News · December | Gaorong Ventures Named Among "China's Top 3 Best VC Funds of 2019," Ronghui "Youth Innovation Camp" Concludes
The future is bright.
